BDULF
Price
$0.60
Change
+$0.01 (+1.67%)
Updated
Dec 19 closing price
Capitalization
10.01B
Intraday BUY SELL Signals
GBCS
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Dec 19 closing price
Capitalization
6.75M
Intraday BUY SELL Signals
Interact to see
Advertisement

BDULF vs GBCS

Header iconBDULF vs GBCS Comparison
Open Charts BDULF vs GBCSBanner chart's image
Bangkok Dusit Medical Services Public
Price$0.60
Change+$0.01 (+1.67%)
Volume$2K
Capitalization10.01B
Selectis Health
Price$2.20
Change-$0.00 (-0.00%)
Volume$1.35K
Capitalization6.75M
BDULF vs GBCS Comparison Chart in %
BDULF
Daily Signal:
Gain/Loss:
GBCS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDULF vs. GBCS commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDULF is a Hold and GBCS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (BDULF: $0.61 vs. GBCS: $2.20)
Brand notoriety: BDULF and GBCS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: BDULF: 48% vs. GBCS: 29%
Market capitalization -- BDULF: $10.01B vs. GBCS: $6.75M
BDULF [@Hospital/Nursing Management] is valued at $10.01B. GBCS’s [@Hospital/Nursing Management] market capitalization is $6.75M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $108.88B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDULF’s FA Score shows that 1 FA rating(s) are green whileGBCS’s FA Score has 1 green FA rating(s).

  • BDULF’s FA Score: 1 green, 4 red.
  • GBCS’s FA Score: 1 green, 4 red.
According to our system of comparison, GBCS is a better buy in the long-term than BDULF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDULF’s TA Score shows that 4 TA indicator(s) are bullish while GBCS’s TA Score has 5 bullish TA indicator(s).

  • BDULF’s TA Score: 4 bullish, 2 bearish.
  • GBCS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BDULF and GBCS are a good buy in the short-term.

Price Growth

BDULF (@Hospital/Nursing Management) experienced а 0.00% price change this week, while GBCS (@Hospital/Nursing Management) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -1.38%. For the same industry, the average monthly price growth was -0.40%, and the average quarterly price growth was +4.32%.

Industries' Descriptions

@Hospital/Nursing Management (-1.38% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDULF($10B) has a higher market cap than GBCS($6.75M). GBCS YTD gains are higher at: 96.429 vs. BDULF (-28.916). BDULF has higher annual earnings (EBITDA): 27.8B vs. GBCS (2M). BDULF has more cash in the bank: 7.05B vs. GBCS (417K). GBCS has less debt than BDULF: GBCS (31.2M) vs BDULF (18.7B). BDULF has higher revenues than GBCS: BDULF (110B) vs GBCS (42.2M).
BDULFGBCSBDULF / GBCS
Capitalization10B6.75M148,192%
EBITDA27.8B2M1,393,484%
Gain YTD-28.91696.429-30%
P/E Ratio18.11N/A-
Revenue110B42.2M260,664%
Total Cash7.05B417K1,690,647%
Total Debt18.7B31.2M59,936%
FUNDAMENTALS RATINGS
BDULF vs GBCS: Fundamental Ratings
BDULF
GBCS
OUTLOOK RATING
1..100
8919
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
51100
PRICE GROWTH RATING
1..100
6044
P/E GROWTH RATING
1..100
8916
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDULF's Valuation (4) in the null industry is significantly better than the same rating for GBCS (71). This means that BDULF’s stock grew significantly faster than GBCS’s over the last 12 months.

BDULF's Profit vs Risk Rating (100) in the null industry is in the same range as GBCS (100). This means that BDULF’s stock grew similarly to GBCS’s over the last 12 months.

BDULF's SMR Rating (51) in the null industry is somewhat better than the same rating for GBCS (100). This means that BDULF’s stock grew somewhat faster than GBCS’s over the last 12 months.

GBCS's Price Growth Rating (44) in the null industry is in the same range as BDULF (60). This means that GBCS’s stock grew similarly to BDULF’s over the last 12 months.

GBCS's P/E Growth Rating (16) in the null industry is significantly better than the same rating for BDULF (89). This means that GBCS’s stock grew significantly faster than BDULF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDULFGBCS
RSI
ODDS (%)
Bearish Trend 2 days ago
30%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
23%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
33%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 4 days ago
20%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
20%
Bullish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
54%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BDULF
Daily Signal:
Gain/Loss:
GBCS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BSJV26.660.01
+0.04%
Invesco BulletShares 2031 HY Corp Bd ETF
LLYX26.33N/A
N/A
Defiance Daily Target 2X Long LLY ETF
UBND21.99-0.01
-0.02%
VictoryShares Core Plus Intmdt Bond ETF
RW25.14-0.02
-0.08%
Rainwater Equity ETF
NCA8.82-0.01
-0.11%
Nuveen California Municipal Value Fund

BDULF and

Correlation & Price change

A.I.dvisor tells us that BDULF and MD have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDULF and MD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDULF
1D Price
Change %
BDULF100%
N/A
MD - BDULF
8%
Poorly correlated
+0.41%
PIII - BDULF
8%
Poorly correlated
-1.11%
NUMIF - BDULF
7%
Poorly correlated
+6.13%
RHEP - BDULF
6%
Poorly correlated
-0.76%
INNV - BDULF
5%
Poorly correlated
-1.07%
More

GBCS and

Correlation & Price change

A.I.dvisor tells us that GBCS and PIII have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GBCS and PIII's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBCS
1D Price
Change %
GBCS100%
N/A
PIII - GBCS
10%
Poorly correlated
-1.11%
PHCI - GBCS
2%
Poorly correlated
-9.51%
AIRS - GBCS
2%
Poorly correlated
-6.45%
DCGO - GBCS
2%
Poorly correlated
+1.20%
BDULF - GBCS
1%
Poorly correlated
N/A
More